Announced details
Healthcare business; manufacturing and marketing of general medical devices
Obtained a medical device marketing license from Tokyo
Class III medical device marketing license
Tokyo Metropolitan Government
License No.: 13B3X10403. License date: 31 March 2026. Valid from 31 March 2026 to 30 March 2031
Nishi-Shinjuku Park West Building, 6-12-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo
The impact on results for the current fiscal year is expected to be limited. Over the medium to long term, the license is expected to contribute to strengthening the earnings base and expanding the business in the healthcare sector.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | General medical devices (Class I), including recovery wear, Proprietary-brand products |
| Counterparty | Tokyo Metropolitan Government |
| Relationship with the Company | Obtained a medical device marketing license from Tokyo |
| Applicable area | Healthcare business; manufacturing and marketing of general medical devices |
| Award/certification name | Class III medical device marketing license |
| Awarding / certifying body | Tokyo Metropolitan Government |
| Registration number and expiry date | License No.: 13B3X10403. License date: 31 March 2026. Valid from 31 March 2026 to 30 March 2031 |
| Location | Nishi-Shinjuku Park West Building, 6-12-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo |
| Impact on Business Performance | The impact on results for the current fiscal year is expected to be limited. Over the medium to long term, the license is expected to contribute to strengthening the earnings base and expanding the business in the healthcare sector. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.By supplying products directly to the market, the Group aims to improve customer convenience and product quality control, streamline the supply chain and improve profit margins. Over the medium to long term, the Group aims to expand and strengthen its healthcare business earnings opportunities and business platform.